Cargando…
Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al.
Autores principales: | Assaad, Souad, Fuhrmann, Christine, Avrillon, Virginie, Ray-Coquard, Isabelle, Blay, Jean-Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474920/ https://www.ncbi.nlm.nih.gov/pubmed/32977222 http://dx.doi.org/10.1016/j.ejca.2020.08.018 |
Ejemplares similares
-
Author Response to Letter to the Editor from CHM van den Ende et al
por: Álvarez, et al.
Publicado: (2020) -
Reply to Liu et al., “Inability To Culture Pneumocystis jirovecii”
por: Schildgen, Verena, et al.
Publicado: (2018) -
Reply to Rockey et al., “Genomics and Chlamydial Persistence In Vivo”
por: Dean, Deborah, et al.
Publicado: (2019) -
Reply to Cabello et al., “Aquaculture and mcr Colistin Resistance Determinants”
por: Shen, Yingbo, et al.
Publicado: (2018) -
Reply to Brandt et al., “Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID”
por: Fogh, Kamille, et al.
Publicado: (2023)